Afatinib for the treatment of non-small cell lung cancer harboring uncommon EGFR mutations: a database of 693 cases

2021 ◽  
Author(s):  
James Chih-Hsin Yang
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Optimal Treatment ◽  
Egfr Mutations ◽  
Small Cell Lung

This Publication Perspective provides a summary of the article ‘Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Database of 693 Cases’ by James Chih-Hsin Yang and co-authors. The paper, originally published in the Journal of Thoracic Oncology, comprehensively analysed the effect of afatinib treatment in 693 patients with non-small cell lung cancer harboring uncommon EGFR mutations. The results provide important information when considering optimal treatment for tumors with uncommon EGFR mutations, including compound mutations.

scholarly journals Direct Comparison of 3 PCR Methods in Detecting EGFR Mutations in Patients with Advanced Non–Small-Cell Lung Cancer

2012 ◽  
Vol 13 (5) ◽  
pp. 369-374 ◽  
Author(s):  
Takaya Ikeda ◽  
Yoichi Nakamura ◽  
Hiroyuki Yamaguchi ◽  
Nanae Tomonaga ◽  
Seiji Doi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Egfr Mutations ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document